Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer De Backer Marianne
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer HANLY ANN M.
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Lee Sung
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer HANLY ANN M.
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer De Backer Marianne
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Lee Sung
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Pang Phillip
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director SCANGOS GEORGE A
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director SCANGOS GEORGE A
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Pang Phillip
Vir Biotechnology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.14%)
Vir Biotechnology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-SVF Endurance (Cayman) Limited(12.4%),SoftBank Vision Fund (AIV M1) L.P.(12.4%), etc.
Vir Biotechnology | SC 13G: Statement of acquisition of beneficial ownership by individuals-STATE STREET CORPORATION(5.14%)
Vir Biotechnology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(12.5%)
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Officer Pang Phillip
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director MORE ROBERT J
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director SCANGOS GEORGE A
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director SCANGOS GEORGE A
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-10% Owner SVF Endurance (Cayman) Ltd
Vir Biotechnology | 4: Statement of changes in beneficial ownership of securities-Director SATO VICKI L
No Data